IMC Chicago
AVXL icon

IMC Chicago’s Anavex Life Sciences AVXL Stock Holding History

IMC Chicago’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$190K Buy
94,000
+4,600
+5% +$12.7K ﹤0.01% 5741
2026
Q2 		$232K Sell
89,400
-63,700
-42% -$188K ﹤0.01% 5513
2026
Q1 		$470K Sell
153,100
-6,600
-4% -$28.6K ﹤0.01% 4109
2025
Q4 		$569K Buy
159,700
+70,500
+79% +$432K ﹤0.01% 3390
2025
Q3 		$794K Buy
89,200
+64,100
+255% +$650K ﹤0.01% 2878
2025
Q2 		$231K Buy
+25,100
New +$214K ﹤0.01% 3213
2025
Q1 		– Sell
-21,200
Closed -$228K – 3112
2024
Q4 		$228K Buy
+21,200
New +$163K ﹤0.01% 3064

Other funds holding AVXL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return